Initial management of immune thrombocytopaenia in adults based on risk stratification

Jaydev Manikkam Umakanthan, Prajwal Dhakal, Krishna Gundabolu, Avyakta Kallam, Daniel R. Almquist, Vijaya R Bhatt

Research output: Contribution to journalReview article

Abstract

Patients with immune thrombocytopaenia (ITP) have a wide spectrum of disease severity and bleeding risk even at similar platelet counts. Hence, additional clinical and laboratory factors may be considered in the evaluation of bleeding risk in ITP. Risk stratification based on predicted bleeding risk may help to identify high-risk patients and guide the initial management of ITP in adults requiring treatment. Recent evidence supports the use of high-dose dexamethasone therapy over prednisone in the initial management of ITP because of improved initial response rates, shorter median time to response and better safety profile. A risk-stratified approach to management of ITP is hoped to reduce bleeding complications in high-risk patients; however, the outcomes of such management approach need to be studied prospectively. Additionally, whether therapy intensification or combination of dual therapy such as intravenous immunoglobulin or rituximab in combination with dexamethasone can reduce bleeding complications in high-risk ITP should be studied in the future.

Original languageEnglish (US)
Pages (from-to)558-562
Number of pages5
JournalPostgraduate Medical Journal
Volume95
Issue number1128
DOIs
StatePublished - Oct 1 2019

Fingerprint

Hemorrhage
Dexamethasone
Intravenous Immunoglobulins
Therapeutics
Prednisone
Platelet Count
Safety

Keywords

  • bleeding risk
  • dexamethasone
  • immune thrombocytopenia
  • steroids
  • thromboelastography

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Initial management of immune thrombocytopaenia in adults based on risk stratification. / Umakanthan, Jaydev Manikkam; Dhakal, Prajwal; Gundabolu, Krishna; Kallam, Avyakta; Almquist, Daniel R.; Bhatt, Vijaya R.

In: Postgraduate Medical Journal, Vol. 95, No. 1128, 01.10.2019, p. 558-562.

Research output: Contribution to journalReview article

Umakanthan, Jaydev Manikkam ; Dhakal, Prajwal ; Gundabolu, Krishna ; Kallam, Avyakta ; Almquist, Daniel R. ; Bhatt, Vijaya R. / Initial management of immune thrombocytopaenia in adults based on risk stratification. In: Postgraduate Medical Journal. 2019 ; Vol. 95, No. 1128. pp. 558-562.
@article{e8c72a5377a04a0798a48e7e5bacc135,
title = "Initial management of immune thrombocytopaenia in adults based on risk stratification",
abstract = "Patients with immune thrombocytopaenia (ITP) have a wide spectrum of disease severity and bleeding risk even at similar platelet counts. Hence, additional clinical and laboratory factors may be considered in the evaluation of bleeding risk in ITP. Risk stratification based on predicted bleeding risk may help to identify high-risk patients and guide the initial management of ITP in adults requiring treatment. Recent evidence supports the use of high-dose dexamethasone therapy over prednisone in the initial management of ITP because of improved initial response rates, shorter median time to response and better safety profile. A risk-stratified approach to management of ITP is hoped to reduce bleeding complications in high-risk patients; however, the outcomes of such management approach need to be studied prospectively. Additionally, whether therapy intensification or combination of dual therapy such as intravenous immunoglobulin or rituximab in combination with dexamethasone can reduce bleeding complications in high-risk ITP should be studied in the future.",
keywords = "bleeding risk, dexamethasone, immune thrombocytopenia, steroids, thromboelastography",
author = "Umakanthan, {Jaydev Manikkam} and Prajwal Dhakal and Krishna Gundabolu and Avyakta Kallam and Almquist, {Daniel R.} and Bhatt, {Vijaya R}",
year = "2019",
month = "10",
day = "1",
doi = "10.1136/postgradmedj-2019-136636",
language = "English (US)",
volume = "95",
pages = "558--562",
journal = "Postgraduate Medical Journal",
issn = "0032-5473",
publisher = "BMJ Publishing Group",
number = "1128",

}

TY - JOUR

T1 - Initial management of immune thrombocytopaenia in adults based on risk stratification

AU - Umakanthan, Jaydev Manikkam

AU - Dhakal, Prajwal

AU - Gundabolu, Krishna

AU - Kallam, Avyakta

AU - Almquist, Daniel R.

AU - Bhatt, Vijaya R

PY - 2019/10/1

Y1 - 2019/10/1

N2 - Patients with immune thrombocytopaenia (ITP) have a wide spectrum of disease severity and bleeding risk even at similar platelet counts. Hence, additional clinical and laboratory factors may be considered in the evaluation of bleeding risk in ITP. Risk stratification based on predicted bleeding risk may help to identify high-risk patients and guide the initial management of ITP in adults requiring treatment. Recent evidence supports the use of high-dose dexamethasone therapy over prednisone in the initial management of ITP because of improved initial response rates, shorter median time to response and better safety profile. A risk-stratified approach to management of ITP is hoped to reduce bleeding complications in high-risk patients; however, the outcomes of such management approach need to be studied prospectively. Additionally, whether therapy intensification or combination of dual therapy such as intravenous immunoglobulin or rituximab in combination with dexamethasone can reduce bleeding complications in high-risk ITP should be studied in the future.

AB - Patients with immune thrombocytopaenia (ITP) have a wide spectrum of disease severity and bleeding risk even at similar platelet counts. Hence, additional clinical and laboratory factors may be considered in the evaluation of bleeding risk in ITP. Risk stratification based on predicted bleeding risk may help to identify high-risk patients and guide the initial management of ITP in adults requiring treatment. Recent evidence supports the use of high-dose dexamethasone therapy over prednisone in the initial management of ITP because of improved initial response rates, shorter median time to response and better safety profile. A risk-stratified approach to management of ITP is hoped to reduce bleeding complications in high-risk patients; however, the outcomes of such management approach need to be studied prospectively. Additionally, whether therapy intensification or combination of dual therapy such as intravenous immunoglobulin or rituximab in combination with dexamethasone can reduce bleeding complications in high-risk ITP should be studied in the future.

KW - bleeding risk

KW - dexamethasone

KW - immune thrombocytopenia

KW - steroids

KW - thromboelastography

UR - http://www.scopus.com/inward/record.url?scp=85072545879&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072545879&partnerID=8YFLogxK

U2 - 10.1136/postgradmedj-2019-136636

DO - 10.1136/postgradmedj-2019-136636

M3 - Review article

VL - 95

SP - 558

EP - 562

JO - Postgraduate Medical Journal

JF - Postgraduate Medical Journal

SN - 0032-5473

IS - 1128

ER -